Plasma glucose and prediction of microvascular disease and mortality: Evaluation of 1997 American Diabetes Association and 1999 World Health Organization criteria for diagnosis of diabets

Diabetes Care

Volumn 23, Issue 8, 2000, Pages 1113-1118

  Gabir, Momin M ^a   Hanson, Robert L ^a   Dabelea, Dana ^a   Imperatore, Giuseppina ^a   Roumain, Janine ^a   Bennett, Peter H ^a   Knowler, William C ^a  

^a NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; DIABETES MELLITUS; DIABETIC MICROANGIOPATHY; DIABETIC NEPHROPATHY; DIABETIC RETINOPATHY; DISEASE ASSOCIATION; EVALUATION; GLUCOSE BLOOD LEVEL; HUMAN; HYPERGLYCEMIA; IMPAIRED GLUCOSE TOLERANCE; MAJOR CLINICAL STUDY; PREDICTION; PREVALENCE; RECEIVER OPERATING CHARACTERISTIC; RISK ASSESSMENT; WORLD HEALTH ORGANIZATION;

EID: 0033868123     PISSN: 01495992     EISSN: None     Source Type: Journal    
DOI: 10.2337/diacare.23.8.1113     Document Type: Article

References (30)

1. Report of the expert committee on the diagnosis and classification of diabetes mellitus
2. Diabetes in older adults: Comparison of 1997 American Diabetes Association classification of diabetes mellitus with 1985 WHO classification
3. Will new diagnostic criteria for diabetes mellitus change phenotype of patients with diabetes? Reanalysis of European epidemiological data
4. Comparison of diabetes diagnostic categories in the U.S. population according to 1997 American Diabetes Association and 1980-1985 World Health Organization diagnostic criteria
5. Comparison of tests for glycated hemoglobin and fasting and two hour plasma glucose concentrations as diagnostic methods for diabetes
6. Comparison of fasting and 2-hour glucose and HbA(1C) levels for diagnosing diabetes: Diagnostic criteria and performance revisited
7. The 1997 American Diabetes Association and 1999 World Health Organization criteria for hyperglycemia in the diagnosis and prediction of diabetes
8. Incidence of proteinuria in type 2 diabetes mellitus in the Pima Indians
9. Impact of NIDDM on mortality and causes of death in Pima Indians
10. Diabetes incidence and prevalence in Pima Indians: A 19-fold greater incidence than in Rochester, Minnesota
11. A method of comparing the areas under receiver operating characteristic curves derived from the same cases
12. Screening, detection, and diagnosis
13. Blood glucose and coronary heart disease
14. The cardiovascular risk associated with impaired glucose tolerance
15. Glucose tolerance and mortality, including a substudy of tolbutamide treatment
16. Diabetes mellitus, impaired glucose tolerance and mortality among elderly men: The Finish cohorts of the seven countries study
17. The effect of diabetes mellitus and impaired glucose tolerance on mortality in Malta
18. Sex differences in fasting glycemia as a risk factor for ischemic heart disease death
19. Fasting blood glucose: An underestimated risk factor for cardiovascular death
20. Impaired glucose tolerance is a risk factor for cardiovascular disease, but not impaired fasting glucose: The Funagata Diabetes Study
21. Risk of diabetes in the new diagnostic category of impaired fasting glucose
22. Glucose tolerance and mortality: Comparison of WHO and American Diabetes Association diagnostic criteria
23. Cardiovascular disease in older adults with glucose disorders: Comparison of American Diabetes Association criteria for diabetes mellitus with WHO criteria
24. Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33)
25. The Diabetes Prevention Program Research Group: The Diabetes Prevention Program: Design and methods for a clinical trial in the prevention of type 2 diabetes mellitus
26. Intra-individual variation of glucose, specific insulin and proinsulin concentrations measured by two oral glucose tolerance tests in general caucasian population: The Hoorn Study